Europe - April 2017
Europe: Latest timings on the new Regulations for medical devices and IVDs
Europe: Products whose principal intended action (depending on PAC present in cranberry) is to prevent or treat cystitis, should not be medical devices
Europe: Joint Action on Market Surveillance of Medical Devices launched at 39th CAMD meeting
Europe: Eucomed and EDMA formally merge to create MedTech Europe
France: Advice for French manufacturers if their Notified Bodies cease operations
Sweden: Responsibility for Notified Bodies to transfer to MPA from SWEDAC
Switzerland: Grace period for manufacturers affected by the de-designation of their Notified Body
UK: Significant fee increases proposed by MHRA to aid cost recovery
Click here for the full article on Global Regulatory Press.
Contact us at email@example.com.